Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 841-860
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Tom Wynn Affiliated at Monashee Investment Management | Boston, United States | Venture debt | Healthcare | ||
 Rick Gerson Co-Founder at Alpha Wave Global | Miami, United States | Private equityVenture debt | AICommerce | ||
 Jan Philipp Kruse Senior Director at Eli Lilly and Company | Berlin, Germany | Corporate VC | AIHealthcare | ||
 Guillaume Pfefer CEO Partner Senda Biosciences at Flagship Pioneering | Boston, United States | AcceleratorVenture capital | AIClimate | ||
 Leyi Wang Partner at 6 Dimensions Capital | Boston, United States | Venture capital | Healthcare | ||
 Marie Yurkovich Biotech Company Creation at Flagship Pioneering | New York City, United States | AcceleratorVenture capital | AIClimate | ||
 Christine S. Li-AuYeung Vice President, Operational Risk Manager at BHI | New York, United States | Venture capitalVenture debt | AIClimate | ||
 Allegra Mulas Venture Portfolio Manager at Eit Health | Zürich, Switzerland | Accelerator | AIHealthcare | ||
 Jerome Bestel Investor (L.P) at Frst | Paris, France | AcceleratorVenture capital | AICommerce | ||
 Sophie de Boer Senior Principal at Flagship Pioneering | Cambridge, United States | AcceleratorVenture capital | AIClimate | ||
 Yoshitake Maeda Venture Partner at Axil Capital Partners, Axil Capital Advisors K.k. | Tokyo, Japan | Venture capital | Healthcare | ||
 Joe Jimenez Co-Founder and Managing Director at Aditum Bio | Oakland, United States | Private equityVenture capital | AIHealthcare | ||
 Sean Algeo Investor at Two River | New York, United States | Private equityVenture capital | Healthcare | ||
 Slanix Paul Alex Investor at Ally Bridge Group | Miami, United States | Private equityVenture debt | Healthcare | ||
 Dillon Booth Investor at Mubadala | United States | Fund of fundsGovernment-backed | ClimateFinTech | ||
 Lennox Ketner Healthcare Investor at Soleus Capital Management | New York, United States | Private equityVenture debt | Healthcare | ||
| Washington, United States | Family Office | EducationHardware | |||
 Théo Risopoulos Investor at Seido Capital | Montreal, Canada | Venture capital | Healthcare | ||
 Kristin Gilbertson Chief Investment Officer at Access Industries | New York, United States | Private equityVenture capital | ConsumerHealthcare | ||
| Cambridge, United States | Venture capital | Healthcare |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal